I doubt the data is very accurate and I would bet it's down much further by the next reading. Shorts probably shorted in large amounts to keep the price down, then started buying dips.
If future prices are higher, the market expects the price to rise. People have written here that Contango is bad for the USO because it has to roll out to a higher price.
or just read "Options as a Strategic Investment" its a great book, but expensive. A good business library may have a copy.
the main question thay have to answer after safety, it does the addition of Bel to Phen work significantly better than just phen. Is the extra cost and any added risk offset by a benefit. Let me know when they answer this.
I want to hear more about the immediate cost reduction plan and then which trials and products are going forward aggressively and which are not and, or is the company being shopped. All management has to say is all options are on the table, but if they say that it might be more difficult to find a good CEO, other than a turnaround and sell specialist, which would be fine with me.
for the past several years, the only long options that have worked were long puts. With the stock at $2.x the stock is priced like a LT option; just buy stock and skip the options IMO.
the first 1MM was all shorting, or so it seems, the following 3MM buying and/or covering. Nice turn, but not keeping up with IBB or XBI today.
they have already declared more than once that the next div is safe. They have not made any announcement about next year as of yet. Price action, considering the hedges, is surprising. They need to focus on COST!!!
maybe that and the request for 5MM additional free shares to give to management. They tanked the last quarter and now they want more free stuff. Bad timing to ask for more shares. Turn the cost picture and stock price around then come back. If you want the cheap shares now, buy some in the open market!
stop the NASH pumping, there is no research into NASH.
This is new, advanced technology, it's not a high-priced biologic, $100,000 treatment that adds 3-4 months to the end of life. USPS, shorts and bad PR/Press have caused a great buying opportunity IMO.
ARNA short and distort campaign is criminal. I just hope ARNA has something real to provide increased shareholder value. If not, people should sue JL personally, not ARNA.
this is just another paid for media tool to spread their opinion/talk their book and lure stupid shorts in for the scraps while slimy Tilson covers. IMO.
Roche must not have a good relationship with IMGN, they always provide negative headlines with no details. Unless there is some recourse on the financing deal it won't have much effect on IMGN, they already sold out of Kadcyla. It might suggest the rest of the pipeline is not all that effective, but that's not a huge surprise. What is a surprise is IMGN in double digits. People never learn as insiders continue to monetize. All IMO and speculation, not advice.
put in a low AH bid and buy some! I would like to have more at that price.
Biotech is down (my guess) because Biden is not running, therefore Hillary will get the blessing and be talking tough on bio-pharma for the next year. Anyone working, or investing in pharma (or stocks in general) would be a fool to vote for her, but she will add headline risk for the next year+.
What a waste of the shareholder money. If I was voting to award just the treasurer, who did the hedging and was kind enough to call me when I had an IR inquiry I would vote yes, (for him only). As for the operators, the people who should be cutting costs, the majority, I vote NO.
come on in, the water is fine he says, I got the first 200%, but you can get the scraps while I exit. Good luck with that!